Adragos Pharma

Munchen, Germany Founded: 2020 • Age: 6 yrs Acquired By FSN Capital
Healthcare sector investments are managed by a private equity fund.

About Adragos Pharma

Adragos Pharma is a company based in Munchen (Germany) founded in 2020 by Andreas Raabe was acquired by FSN Capital in August 2021.. Adragos Pharma has completed 2 acquisitions, including Baccinex and Lamda.

  • Headquarter Munchen, Germany
  • Founders Andreas Raabe
  • Sectors
    Financial Services
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Financial Services → Private Capital & Alternative Investments
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Investments & Acquisitions
    Baccinex

    & 1 more

  • Acquired by
    FSN Capital

    (Aug 09, 2021)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal
People of Adragos Pharma
Headcount
Employee Profiles 31
Employee Profiles
People
Dhanashree Jadhav
Manager Corporate Accounting And Consolidation
People
Laura Mary
Director Of Business Development
People
Gilles Jost
Project Lead | Manufacturing Science & Technologie
People
Andreas Raabe
CEO

Unlock access to complete

Funding Insights of Adragos Pharma

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Adragos Pharma

Adragos Pharma has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include FSN Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
-
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Adragos Pharma

Adragos Pharma has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Baccinex and Lamda. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
CDMO specializing in fill and finishing of sterile lyophilized or liquid dosage forms
1999
Laboratory focused on generic drugs development and research services
1996
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Adragos Pharma

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Adragos Pharma Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Adragos Pharma

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Adragos Pharma

Frequently Asked Questions about Adragos Pharma

When was Adragos Pharma founded?

Adragos Pharma was founded in 2020.

Where is Adragos Pharma located?

Adragos Pharma is headquartered in Munchen, Germany. It is registered at Munchen, Bayern, Germany.

Who is the current CEO of Adragos Pharma?

Andreas Raabe is the current CEO of Adragos Pharma. They have also founded this company.

What does Adragos Pharma do?

Adragos Pharma private equity fund investing in healthcare sectors through investment industry, private equity funds, and buyout funds. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.

How many acquisitions has Adragos Pharma made?

Adragos Pharma has made 2 acquisitions, including Baccinex, and Lamda.

Who are Adragos Pharma's investors?

Adragos Pharma has 1 investor. Key investors include FSN Capital.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available